Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$246.03

-0.03 (-0.01%)

, BLK

BlackRock

$462.61

-1.825 (-0.39%)

11:27
10/06/17
10/06
11:27
10/06/17
11:27

The Intersection: Crypto and Wall Street This Week

As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. GOLDMAN EXPLORES BITCOIN: Goldman Sachs (GS) is in the early stages of a potential new trading operation dedicated to bitcoin and other cryptocurrencies, The Wall Street Journal reported on Monday, saying Goldman still may not proceed with the effort. "In response to client interest in digital currencies we are exploring how best to serve them in this space," a spokeswoman said. On Tuesday, Goldman CEO Lloyd Blankfein tweeted: "Still thinking about #Bitcoin. No conclusion - not endorsing/rejecting. Know that folks also were skeptical when paper money displaced gold." 2. BLACKROCK CEO SKEPTICAL: In an interview with Bloomberg News on Tuesday, BlackRock (BLK) CEO Larry Fink said, "Related to cryptocurrencies, I'm a big believer in the potential of what a cryptocurrency can do. You see huge opportunities, but what we're talking about today, it's much more of a speculative platform, people are speculating on it," he said. However, Fink added that bitcoin's growth "just identifies how much money laundering there is being done in the world. How much people are trying to move currencies from one place to another." 3. ECB DISCUSSES DIGITAL: The European Central Bank has begun to seriously discuss putting "concrete legal restrictions in place" for digital currencies and is mulling regulation around initial coin offerings, Bloomberg reported on Thursday, citing comments made by council member Ewald Nowotny. He added the "hype" around cryptocurrency is "dangerous and deeply dubious." The move comes after ECB president Mario Draghi previously said that "it would actually not be in our powers to prohibit and regulate" cryptocurrency. 4. COINBASE CRASH: The Commodity Futures Trading Commission has requested information from digital-coin exchange Coinbase over a June flash crash that saw the ether digital token drop to 10c from $317.81 before recovering, Bloomberg reported on Monday. The watchdog is looking into what role leverage played in the drop on Coinbase's GDAX platform as the exchange enabled traders to use borrowed money to make larger wagers. The plunge was caused by a single $12.5M trade resulting in selling which triggered automatic sell orders. Algorithms then began issuing buy orders that brought prices back up to $300 within 10 seconds. Coinbase, which is not registered with the CFTC, said "it fully cooperates with regulators." 5. BIOPTIX BECOMES RIOT: On Wednesday, Bioptix (BIOP) announced it was changing its name to Riot Blockchain (RIOT) in line with a shift in direction to become a strategic investor and operator in the blockchain ecosystem with a focus on Bitcoin and Ethereum. As part of this focus, the company announced it made a strategic investment in Canadian exchange Coinsquare. Riot is investing a few millions dollars for about a 12% stake and has warrants to increase its holding to 20%, Bloomberg reported. The company is also looking to acquire businesses focused on bitcoin mining, blockchain and security software. 6. NVIDIA'S LEAD SEEN WIDENING: On Wednesday, Barclays analyst Blayne Curtis raised his price target for Nvidia (NVDA) shares to $200 from $140 while keeping an Equal Weight rating on the name. The launch of Volta based client graphic processing units in early 2018 should widen the company's lead, Curtis said in a U.S. Semiconductors research note titled "Crypto Tailwind Likely Extends into Next Year." The GPU market is still in shortage but should start to recover into the end of the year, the analyst writes. He sees this as positive for both Nvidia and AMD (AMD). The analyst raised his price target for AMD shares to $10 from $9 but keeps an Underweight rating on the name. In prior research, Jefferies' analyst Mark Lipacis told investors that he estimates cryptocurrency revenues accounted for about 3% of quarterly sales for Advanced Micro Devices and about 10% for Nvidia in the second quarter. PRICE ACTION: As of time of writing, Bitcoin rose about 4.2% this week, or $178, to $4,389 in U.S. dollars. Meanwhile, AMD shares were up about 4% to $13.26 this week and Nvidia rose 1.3% on a weekly basis to $189.96. Bitcoin Investment Trust (GBTC) dropped 2.6% this week to $700.99. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.

GS

Goldman Sachs

$246.03

-0.03 (-0.01%)

BLK

BlackRock

$462.61

-1.825 (-0.39%)

BIOP

Bioptix

RIOT

Riot Blockchain

$7.30

-0.88 (-10.76%)

NVDA

Nvidia

$180.77

-0.1 (-0.06%)

AMD

AMD

$13.34

0.03 (0.23%)

GBTC

Bitcoin Investment Trust

$696.00

11.375 (1.66%)

BITCOIN

Bitcoin

  • 11

    Oct

  • 17

    Oct

  • 22

    Oct

  • 07

    Nov

GS Goldman Sachs
$246.03

-0.03 (-0.01%)

09/26/17
DBAB
09/26/17
DOWNGRADE
Target $136
DBAB
Hold
PNC Financial downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded PNC Financial (PNC) to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes a number of positives are priced into PNC shares. O'Connor upped his price target for the stock to $136 from $130. The analyst continues to prefer banks with a "turnaround angle," like Goldman Sachs (GS) and Wells Fargo (WFC), and remains positive on capital markets businesses like Morgan Stanley (MS). O'Connor this morning also downgraded JPMorgan (JPM) to Hold.
09/12/17
KBWI
09/12/17
NO CHANGE
KBWI
Market Perform
Keefe Bruyette 'somewhat skeptical' of Goldman Sachs revenue targets
Keefe Bruyette analyst Brian Kleinhanzl noted that Goldman Sachs co-COO Harvey Schwartz identified $5B in revenue opportunities that the company sees over the next 3 years, though he is "somewhat skeptical" of the bank's ability to hit these targets given that its strategy requires penetrating new markets or segments outside of its traditional strengths. The analyst, who thinks Goldman remains a "show-me stock," keeps a Market Perform rating on the shares.
08/11/17
HSBC
08/11/17
DOWNGRADE
HSBC
Hold
Goldman Sachs downgraded to Hold from Buy at HSBC
08/09/17
WELS
08/09/17
INITIATION
Target $265
WELS
Outperform
Goldman Sachs resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Goldman Sachs (GS) with an Outperform rating and $265 price target. The analyst prefers Goldman over Morgan Stanley (MS), saying the bank has about "twice as fast" organic revenue growth for more than 20 years, and "much faster" earnings growth over 15 years. Mayo named Citi (C) his top pick among the Large-Cap banks.
BLK BlackRock
$462.61

-1.825 (-0.39%)

09/08/17
LEHM
09/08/17
INITIATION
Target $475
LEHM
Overweight
BlackRock initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started BlackRock with an Overweight rating and $475 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
09/15/17
JPMS
09/15/17
NO CHANGE
Target $551
JPMS
Overweight
BlackRock shares will hold up in market correction, says JPMorgan
BlackRock shares will hold up better than peers in a U.S. market correction, JPMorgan analyst Kenneth Worthington tells investors in a research note. The analyst notes that with U.S. equity markets reaching all-time highs, he increasingly hears investor concerns about investing in asset managers. He believes BlackRock has demonstrated that it can maintain positive sales and organic growth even when equity U.S. markets sell off. The analyst keeps an Overweight rating on the shares with a $551 price target.
09/28/17
GSCO
09/28/17
UPGRADE
Target $500
GSCO
Conviction Buy
BlackRock upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Alexander Blostein upgraded BlackRock and added it to the Conviction Buy List with a $500 price target. The analyst has expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its Tech platform which should lead to sustainable multiple improvement.
09/28/17
09/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Neutral at Longbow with analyst Alton Stump citing better than expected third quarter U.S. comparable store sales trends. 2. Philip Morris (PM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Judy Hong saying the company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products. 3. BlackRock (BLK) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Blostein saying he expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its tech platform which should lead to sustainable multiple improvement. 4. Potbelly (PBPB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Nicole Miller Regan saying she believes a "compelling" turnaround is building. 5. Huntsman (HUN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Frank Mitsch saying the recent weakness in the shares is a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BIOP Bioptix

RIOT Riot Blockchain
$7.30

-0.88 (-10.76%)

NVDA Nvidia
$180.77

-0.1 (-0.06%)

09/29/17
SBSH
09/29/17
NO CHANGE
Target $210
SBSH
Buy
Citi boosts Nvidia target to $210 on artificial intelligence opportunity
Citi analyst Atif Malik raised his price target for Nvidia (NVDA) shares to $210 to reflect higher data center inference sales supported by recent announcements with China's Alibaba Cloud (BABA), Baidu (BIDU), and Tencent (TCEHY). Nvidia closed yesterday down 5c to $175.68. The Street views the company as dominant in training but an underdog in inferencing, Malik tells investors in a research note titled "The State of AI Today; Raising TP on AI Inference Opportunity." He points out that Nvidia's new TensorRT software platform and Tesla (TSLA) GPU accelerators are 40 times faster than CPUs at one-tenth the cost of CPU-based solutions. Nvidia targets to participate in high level edge inferencing for smart cities, manufacturing, and robotics end markets, Malik writes. He adds that his firm's updated proprietary gaming survey indicates AMD's (AMD) new Vega graphics cards represent a "limited threat." The analyst believes Nvidia's risk/reward remains skewed to the upside and he keeps a Buy rating on the shares.
10/02/17
RHCO
10/02/17
NO CHANGE
RHCO
Nvidia price target raised to $200 from $181 at SunTrust
SunTrust analyst William Stein increased his price target on Nvidia as he says new products and customer contracts announced by the company involving the use of AI in datacenters make his bullish scenario for Nvidia more likely. He keeps a Buy rating on the shares.
10/04/17
LEHM
10/04/17
NO CHANGE
Target $200
LEHM
Equal Weight
Nvidia price target raised to $200 from $140 at Barclays
Barclays analyst Blayne Curtis raised his price target for Nvidia shares to $200 while keeping an Equal Weight rating on the name. The launch of Volta based client graphic processing units in early 2018 should widen the company's lead, Curtis tells investors in a research note on the U.S. Semiconductors space titled "Crypto Tailwind Likely Extends into Next Year." The GPU market is still in shortage but should start to recover into the end of the year, the analyst writes. He sees this as positive for both Nvidia and AMD (AMD). The analyst raised his price target for AMD shares to $10 from $9 but keeps an Underweight rating on the name. Curtis remains cautious saying AMD's share gains are not materializing to justify the current stock price.
10/05/17
LOOP
10/05/17
NO CHANGE
Target $205
LOOP
Buy
Nvidia price target raised to $205 from $181 at Loop Capital
Loop Capital analyst Betsy Van Hees raised her price target for Nvidia to $205 on expectations of upside to estimates in the second half of the company's fiscal 2018. The chipmaker closed yesterday up $1.50 to $180.87. An "impressive slate" of fall video game releases will drive better than expected demand for GeForce GTX series GPUs in Q3, Van Hees tells investors in a research note. Further, the analyst sees continued demand from crypto currency mining and broad adoption of Volta-based V100 GPUs pushing the company's Data Center revenue growth back to double-digit quarter-over-quarter. Van Hees keeps a Buy rating on Nvidia.
AMD AMD
$13.34

0.03 (0.23%)

09/21/17
BERN
09/21/17
NO CHANGE
BERN
Working with Tesla would be incremental positive for AMD, says Bernstein
Bernstein analyst Stacy Rasgon notes that CNBC reported that Tesla (TSLA) is working with AMD (AMD) to develop its own AI chips for self-driving cars. Regardless of whether AMD is truly contributing or not, the analyst points out that the idea of Tesla eventually doing their own self-driving chipsets should not be a surprise to anyone, and if it is not happening now it likely will at some point. If true, Rasgon believes the news would probably be an incremental positive for AMD, and an incremental negative for Nvidia (NVDA).
09/21/17
BOFA
09/21/17
NO CHANGE
BOFA
Tesla shift to AMD from Nvidia has limited impact on either, says BofA/Merrill
BofA/Merrill analyst Vivek Arya said news reports Tesla (TSLA) is considering a shift to AMD's (AMD) internal chips from Nvidia's (NVDA) will have limited material impact on either near-term. The analyst said Tesla accounts for less than 1% of Nvidia sales and has a much bigger opportunity with other automakers such as Toyota and Audi and the potential win for AMD is more positive for perception than in numbers. Arya maintains a Buy rating on Nvidia given its data center and gaming franchises and potential growth opportunities in autonomous cars. He maintains a Buy rating on AMD to reflect potential share gains in server and PC markets, and for incremental opportunities to leverage IP in other markets.
09/21/17
RBCM
09/21/17
NO CHANGE
RBCM
Nvidia likely to continue partnering with Tesla, says RBC Capital
After CNBC and other media outlets reported that Tesla (TSLA) would work with AMD (AMD) to improve its self-driving car chips, RBC Capital analyst Mitch Steves expects Nvidia to continue to work with Tesla and remain the dominant chip provider to the automaker. He expects "similar dynamics" to play out in the data center space, with AMD "winning some share" in the sector, and Nvidia "remaining as the de-facto standard and market share leader." He notes that Toyota (TM) and Uber both use Nvidia's technology, and he does not expect the loss of share at Tesla to impact the chip maker over the long-term. He keeps an Outperform rating on Nvidia.
GBTC Bitcoin Investment Trust
$696.00

11.375 (1.66%)

BITCOIN Bitcoin

TODAY'S FREE FLY STORIES

AAPL

Apple

$159.76

-0.71 (-0.44%)

, HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Periodicals
Apple, suppliers fall after report of reduced iPhone 8 orders, Bloomberg says »

Shares of Apple (AAPL)…

AAPL

Apple

$159.76

-0.71 (-0.44%)

HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

GALT

Galectin Therapeutics

$2.51

0.22 (9.61%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Initiation
Galectin Therapeutics initiated  »

Galectin Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$47.52

0.51 (1.08%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

RMBL

RumbleON

$9.30

0.3 (3.33%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Syndicate
RumbleON 2.91M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

XPO

XPO Logistics

$64.76

0.12 (0.19%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Hot Stocks
Department of Defense boosts XPO contract by $139.5M to $2.32B »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

GEMP

Gemphire Therapeutics

$9.54

-0.08 (-0.83%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Initiation
Gemphire Therapeutics initiated  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$37.97

0.48 (1.28%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Recommendations
eBay analyst commentary  »

eBay progress…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Hot Stocks
Genuine Parts announces two industrial and automotive acquisitions »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

BANR

Banner Corp.

$61.29

0.54 (0.89%)

, PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

08:38
10/19/17
10/19
08:38
10/19/17
08:38
Conference/Events
People's Utah Bancorp to hold a conference call »

Management discusses…

BANR

Banner Corp.

$61.29

0.54 (0.89%)

PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 26

    Oct

  • 09

    Nov

MTG

MGIC Investment

$13.54

0.43 (3.28%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
MGIC Investment analyst commentary  »

MGIC Investment price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$153.00

2.62 (1.74%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

IFMK

iFresh

$12.15

-0.1 (-0.82%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Hot Stocks
iFresh announces exclusive agreement with Dragon Seeds »

iFresh announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.00

-0.05 (-0.71%)

08:36
10/19/17
10/19
08:36
10/19/17
08:36
Technical Analysis
Technical View: Corbus Pharmaceuticals surges on anabasum Phase 2 results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$12.33

0.01 (0.08%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Hot Stocks
Celestica appoints Mandeep Chawla as CFO »

Celestica announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Hot Stocks
Genuine Parts CEO: Q3 'presented us with both opportunities and challenges' »

Paul Donahue, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

AXP

American Express

$92.08

0.39 (0.43%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Recommendations
American Express analyst commentary  »

American Express guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 08

    Nov

AXP

American Express

$92.08

0.39 (0.43%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 08

    Nov

AGEN

Agenus

$4.71

0.04 (0.86%)

, ADRO

Aduro Biotech

$9.55

-0.1 (-1.04%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call Aduro Biotech »

Biotech Analyst Phipps,…

AGEN

Agenus

$4.71

0.04 (0.86%)

ADRO

Aduro Biotech

$9.55

-0.1 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 24

    Oct

ARNA

Arena Pharmaceuticals

$27.56

0.71 (2.64%)

08:34
10/19/17
10/19
08:34
10/19/17
08:34
Hot Stocks
Arena Pharmaceuticals reports Phase 2 results of ralinepag in hypertension »

Arena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VCYT

Veracyte

$9.19

0.29 (3.26%)

08:33
10/19/17
10/19
08:33
10/19/17
08:33
Hot Stocks
Veracyte to present data on Percepta Bronchial Genomic Classifier at CHEST 2017 »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:32
10/19/17
10/19
08:32
10/19/17
08:32
Earnings
Genuine Parts cuts FY17 adjusted EPS view to $4.55-$4.60 from $4.70-$4.75 »

FY17 consensus $4.73.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

08:32
10/19/17
10/19
08:32
10/19/17
08:32
General news
Jobless Claims data reported »

Week of 10/14 Jobless…

ADBE

Adobe

$153.00

2.62 (1.74%)

08:32
10/19/17
10/19
08:32
10/19/17
08:32
Recommendations
Adobe analyst commentary  »

Adobe growth, margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

08:32
10/19/17
10/19
08:32
10/19/17
08:32
General news
Philadelphia Fed Business Outlook Survey General Conditions Index data reported »

October Philadelphia Fed…

W

Wayfair

$67.13

-0.63 (-0.93%)

08:32
10/19/17
10/19
08:32
10/19/17
08:32
Initiation
Wayfair initiated  »

Wayfair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.